These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21109529)

  • 1. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression.
    Grammatikakis I; Goo YH; Echeverria GV; Cooper TA
    Nucleic Acids Res; 2011 Apr; 39(7):2769-80. PubMed ID: 21109529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.
    Fleming VA; Geng C; Ladd AN; Lou H
    BMC Mol Biol; 2012 Dec; 13():35. PubMed ID: 23227900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.
    Pascual M; Vicente M; Monferrer L; Artero R
    Differentiation; 2006 Mar; 74(2-3):65-80. PubMed ID: 16533306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron.
    Echeverria GV; Cooper TA
    Nucleic Acids Res; 2014 Feb; 42(3):1893-903. PubMed ID: 24185704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer.
    Sen S; Talukdar I; Liu Y; Tam J; Reddy S; Webster NJ
    J Biol Chem; 2010 Aug; 285(33):25426-37. PubMed ID: 20519504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
    Ladd AN; Charlet N; Cooper TA
    Mol Cell Biol; 2001 Feb; 21(4):1285-96. PubMed ID: 11158314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscleblind proteins regulate alternative splicing.
    Ho TH; Charlet-B N; Poulos MG; Singh G; Swanson MS; Cooper TA
    EMBO J; 2004 Aug; 23(15):3103-12. PubMed ID: 15257297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CELF splicing activation and repression domains in vivo.
    Han J; Cooper TA
    Nucleic Acids Res; 2005; 33(9):2769-80. PubMed ID: 15894795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBNL1 and PTB cooperate to repress splicing of Tpm1 exon 3.
    Gooding C; Edge C; Lorenz M; Coelho MB; Winters M; Kaminski CF; Cherny D; Eperon IC; Smith CW
    Nucleic Acids Res; 2013 May; 41(9):4765-82. PubMed ID: 23511971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
    Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
    Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.
    Terenzi F; Ladd AN
    RNA Biol; 2010; 7(1):43-55. PubMed ID: 20009516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
    Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
    EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development.
    Ladd AN; Stenberg MG; Swanson MS; Cooper TA
    Dev Dyn; 2005 Jul; 233(3):783-93. PubMed ID: 15830352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic determinants of MBNL activity.
    Sznajder ŁJ; Michalak M; Taylor K; Cywoniuk P; Kabza M; Wojtkowiak-Szlachcic A; Matłoka M; Konieczny P; Sobczak K
    Nucleic Acids Res; 2016 Dec; 44(21):10326-10342. PubMed ID: 27733504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting domains necessary for activation and repression of splicing by Muscleblind-like protein 1.
    Edge C; Gooding C; Smith CW
    BMC Mol Biol; 2013 Dec; 14():29. PubMed ID: 24373687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.
    Lee KS; Cao Y; Witwicka HE; Tom S; Tapscott SJ; Wang EH
    J Biol Chem; 2010 Oct; 285(44):33779-87. PubMed ID: 20709755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.
    Carpentier C; Ghanem D; Fernandez-Gomez FJ; Jumeau F; Philippe JV; Freyermuth F; Labudeck A; Eddarkaoui S; Dhaenens CM; Holt I; Behm-Ansmant I; Marmier-Gourrier N; Branlant C; Charlet-Berguerand N; Marie J; Schraen-Maschke S; Buée L; Sergeant N; Caillet-Boudin ML
    Biochim Biophys Acta; 2014 Apr; 1842(4):654-64. PubMed ID: 24440524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.